Natural molecules for enhancing electrolyte and water absorption
Innovative formulations using natural molecules aim to correct altered membrane transport proteins, improving electrolyte and water absorption to address various disease states. This technology builds on extensive research and over 100 patents, currently at TRL 6.
Overview
This cutting-edge technology leverages natural molecules to address dysregulation of key transport molecules associated with various disease states. By correcting alterations in membrane transport proteins, these formulations aim to enhance electrolyte and water absorption, offering a novel approach to improving physiological functions and potentially mitigating disease symptoms. The technology is based on extensive research, including over 100 patents, exploring the regulation of transporters through simple nutrients and select amino acids.
Technical specifications
- Natural molecules: Utilizes select amino acids and nutrients to regulate key transporters.
- Formulations: Multiple patented formulations developed to enhance absorption during both digestive and inter-digestive phases.
- Research foundation: Built on findings from the University of Florida, demonstrating the efficacy of nutrients in correcting transport protein dysregulation.
- Applications: Potentially applicable across various disease states linked to electrolyte and water absorption issues.
Technology readiness level
This technology is currently at Technology Readiness Level 6, indicating that it has been validated in relevant environments and is ready for further development and potential commercialization. Future validation and research plans will be tailored through collaboration and partnership with interested companies.
About University of Florida
The University of Florida is a comprehensive public research university with a broad academic and research portfolio and a statewide presence. Industry collaborates through co-located labs and shared core facilities and through an integrated academic health system that accelerates clinical translation. A statewide extension network and multiple research and education sites connect companies with field-scale testing and rapid deployment, while incubators and an adjacent innovation district provide pathways from lab to market. Research is supported by competitive funding from major federal agencies such as NIH, NSF, USDA, and DOE. A dedicated technology transfer office supports IP, licensing, and startup formation.
delivered to your inbox.